Pneumococci responsible for invasive disease and discharging ears in children in Sydney, Australia

Journal of Medical Microbiology

Volumn 56, Issue 6, 2007, Pages 819-823

  Watson, Michael ^a,b   Brett, Maggie ^a   Brown, Mitchell ^a,c   Stewart, Marianne G ^a   Warren, Shirley ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b Clinipath Pathology   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CLONE; CONTROLLED STUDY; CULTURE MEDIUM; EAR DISCHARGE; EAR INFECTION; HUMAN; INFANT; INVASIVE PNEUMOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

AUSTRALIA; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; EAR DISEASES; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 34250363140     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47057-0     Document Type: Article

References (19)

1. Black, S. & Shinefield, H. R. (2002). Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California. Eur J Pediatr 161 (Suppl. 2), S127-S132.
2. Clarke, S. C., Scott, K. J. & McChlery, S. M. (2004). Serotypes and sequence types of pneumococci causing invasive disease in Scotland prior to the introduction of pneumococcal conjugate polysaccharide vaccines. J Clin Microbiol 42, 4449-4452.
3. Enright, M. C. & Spratt, B. G. (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144, 3049-3060.
4. Eskola, J., Kilpi, T., Palmu, A., Jokinen, J., Haapakoski, J., Herva, E., Takala, A., Kayhty, H., Karma, P. & other authors (2001). Efficacy of a pneumococcal conjugate vaccine against acute otitis media. Finnish Otitis Media Study Group. N Engl J Med 344, 403-409.
5. Gertz, R. E., McEllistrem, M. C., Boxrud, D. J., Li, Z., Sakota, V., Thompson, T. A., Facklam, R. R., Besser, J. M., Harrison, L. H. & other authors (2003). Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41, 4194-4216.
6. Hansman, D. & Bullen, M. M. (1967). A resistant pneumococcus. Lancet 2, 264-265.
7. Hogg, G. G., Strachan, J. E. & Lester, R. A. (2000). Invasive pneumococcal disease in the population of Victoria. Med J Aust 173 (Suppl.), S32-S35.
8. Jette, L. P. & Lamothe, F. (1989). Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol 27, 1-5.
9. Kertesz, D. A., Di Fabio, J. L., de Cunto Brandileone, M. C., Castaneda, E., Echaniz-Aviles, G., Heitmann, I., Homma, A., Hortal, M., Lovgren, M. & other authors (1998). Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study. PA HO Pneumococcal Surveillance Study Group. Clin Infect Dis 26, 1355-1361.
10. McGee, L., Klugman, K. P., Wasas, A., Capper, T. & Brink, A. Antibiotics Surveillance Forum of South Africa (2001). Serotype 19F multiresistant pneumococcal clone harbouring two erythromycin resistance determinants [crm(B) and mef(A)] in South Africa. Antimicrob Agents Chemother 45, 1595-1598.
11. NCCLS (2003). Performance Standards for Antimicrobial Disk Susceptibility Test, 8th edn. Approved standard M2-A8. Wayne, PA: National Committee for Laboratory Standards.
12. Nielsen, S. V. & Henrichsen, J. (1992). Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin Infect Dis 15, 794-798.
13. Pai, R., Moore, M. R., Pilishvili, T., Gertz, R. E., Whitney, C. G. & Beall, B. Active Bacterial Core Surveillance Team (2005). Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192, 1988-1995.
14. Serrano, I., Melo-Cristino, J., Carriço, J. A. & Ramirez, M. (2005). Characterization of the genetic lineages responsible for pneumococcal invasive disease in Portugal. J Clin Microbiol 43, 1706-1715.
15. Shi, Z. Y., Enright, M. C., Wilkinson, P., Griffiths, D. & Spratt, B. G. (1998). Identification of the three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequencing typing. J Clin Microbiol 36, 3514-3519.
16. Turnidge, J. D., Bell, J. M. & Collignon, P. J. (1999). Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Med J Aust 170, 152-155.
17. van Belkum, A., Sluijter, M., de Groot, R., Verbrugh, H. & Hermans, P. W. M. (1996). Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains. J Clin Microbiol 34, 1176-1179.
18. Watson, M., Roche, P., Bayley, K., Bell, J. M., Collignon, P., Gilbert, G. L., Hogg, G., Keil, A. D., Krause, V. & other authors (2004). Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program. Commun Dis Intell 28, 455-464.
19. Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T. & other authors (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. Active Bacterial Core Surveillance of the Emerging Infections Program Network. N Engl J Med 348, 1737-1746.